Join the Malaria group to help and get support from people like you.
Malaria News
Mystery Illness Outbreak in Congo May Be Malaria
THURSDAY, Dec. 12, 2024 – There's early evidence that a mysterious flu-like illness that has sickened 416 people and left 75 dead in the Democratic Republic of Congo over recent weeks may be...
Malaria Developing Resistance to Drug That Saves Children's Lives
THURSDAY, Nov. 14, 2024 – Over 600,000 people worldwide die from mosquito-borne malaria each year, with the majority of these deaths happening among children under 5. Now, there's troubling news...
Diagnostic Device Spots Malaria Without Need for Blood Sample
THURSDAY, Oct. 31, 2024 – Scans using lasers and ultrasound can pick up signs of a malaria infection through the skin, without the need for a blood draw, Yale researchers report. The technology,...
Mosquitos Have Another Way to Find You: Body Heat
MONDAY, Aug. 26, 2024 – Body heat is a powerful means by which mosquitos find human beings to bite, a new study shows. Mosquitos were twice as drawn to a target in a laboratory if the source emitted...
Mosquitos: Get Them to Buzz Off
SATURDAY, Aug. 17, 2024 – It's that time of year when mosquitoes are at their peak, buzzing around barbecues and stinging at will. But you don't have to become their next victim, says one expert who...
FDA Approves Artesunate for Injection for the Treatment of Severe Malaria
FREDERICK, Md., May 27, 2020 /PRNewswire/ – Amivas (US), LLC, specialists in treatments for rare and neglected tropical diseases, including severe malaria, announced today that Artesunate for...
FDA Approves Arakoda (tafenoquine) for the Prevention of Malaria
WASHINGTON, Aug. 9, 2018 /PRNewswire/ – 60 Degrees Pharmaceuticals (60P) announced today the U.S. Food and Drug Administration (FDA) approval of Arakoda (tafenoquine) tablets for the prevention of...
FDA Approves Krintafel (tafenoquine) for the Radical Cure of Plasmodium vivax Malaria
London UK; Philadelphia US; Geneva, Switzerland - July 20, 2018 – GSK and Medicines for Malaria Venture (MMV) today announced that the United States Food and Drug Administration (FDA) has approved,...
FDA Medwatch Alert: Mefloquine Hydrochloride: Drug Safety Communication - Label Changes Due To Risk of Serious Psychiatric and Nerve Side Effects
ISSUE: FDA is advising the public about strengthened and updated warnings regarding neurologic and psychiatric side effects associated with the antimalarial drug mefloquine hydrochloride. A boxed...
Further information
Related drug support groups
doxycycline, clindamycin, hydroxychloroquine, Plaquenil, sulfamethoxazole